A phase 4, open-label, multi-centre, observational extension study monitoring the long-term safety and efficacy of adefovir dipivoxil 10mg daily in treatment experienced patients with chronic hepatitis B.
Phase of Trial: Phase IV
Latest Information Update: 21 Jun 2016
At a glance
- Drugs Adefovir dipivoxil (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Gilead Sciences
- 08 Jun 2016 Status changed from recruiting to completed.
- 26 May 2011 New trial record